Berggren Elisabet, Amcoff Patric, Benigni Romualdo, Blackburn Karen, Carney Edward, Cronin Mark, Deluyker Hubert, Gautier Francoise, Judson Richard S, Kass Georges E N, Keller Detlef, Knight Derek, Lilienblum Werner, Mahony Catherine, Rusyn Ivan, Schultz Terry, Schwarz Michael, Schüürmann Gerrit, White Andrew, Burton Julien, Lostia Alfonso M, Munn Sharon, Worth Andrew
Joint Research Centre, European Commission, Ispra, Italy.
Environ Health Perspect. 2015 Dec;123(12):1232-40. doi: 10.1289/ehp.1409342. Epub 2015 May 8.
Safety assessment for repeated dose toxicity is one of the largest challenges in the process to replace animal testing. This is also one of the proof of concept ambitions of SEURAT-1, the largest ever European Union research initiative on alternative testing, co-funded by the European Commission and Cosmetics Europe. This review is based on the discussion and outcome of a workshop organized on initiative of the SEURAT-1 consortium joined by a group of international experts with complementary knowledge to further develop traditional read-across and include new approach data.
The aim of the suggested strategy for chemical read-across is to show how a traditional read-across based on structural similarities between source and target substance can be strengthened with additional evidence from new approach data--for example, information from in vitro molecular screening, "-omics" assays and computational models--to reach regulatory acceptance.
We identified four read-across scenarios that cover typical human health assessment situations. For each such decision context, we suggested several chemical groups as examples to prove when read-across between group members is possible, considering both chemical and biological similarities.
We agreed to carry out the complete read-across exercise for at least one chemical category per read-across scenario in the context of SEURAT-1, and the results of this exercise will be completed and presented by the end of the research initiative in December 2015.
重复剂量毒性的安全性评估是替代动物实验过程中最大的挑战之一。这也是SEURAT - 1概念验证的目标之一,SEURAT - 1是有史以来最大的由欧盟委员会和欧洲化妆品协会联合资助的关于替代测试的研究计划。本综述基于由SEURAT - 1联盟发起组织的一次研讨会的讨论内容和成果,该研讨会有一批具有互补知识的国际专家参加,以进一步发展传统的类推法并纳入新方法数据。
化学类推法建议策略的目的是展示如何利用新方法数据(例如来自体外分子筛选、“组学”分析和计算模型的信息)的额外证据,加强基于源物质和目标物质结构相似性的传统类推法,以获得监管部门的认可。
我们确定了四种类推情况,涵盖典型的人类健康评估情形。对于每种此类决策背景,我们建议了几个化学类别作为示例,以证明在考虑化学和生物学相似性的情况下,组成员之间何时可以进行类推。
我们同意在SEURAT - 1的背景下,针对每种类推情况至少对一个化学类别进行完整的类推操作,该操作结果将在2015年12月研究计划结束前完成并公布。